Year: 2018
Type: article
Abstract: Multiple interventions in the aging process have been discovered to extend the healthspan of model organisms. Both industry and academia are therefore exploring possible transformative molecules that target aging and age-associated diseases. In this overview, we summarize the presented talks and discussion points of the 5th Annual Aging and Drug Discovery Forum 2018 in Basel, Switzerland. Here academia and industry came together, to discuss the latest progress and issues in aging research. The meeting covered talks about the mechanistic cause of aging, how longevity signatures may be highly conserved, emerging biomarkers of aging, possible interventions in the aging process and the use of artificial intelligence for aging research and drug discovery. Importantly, a consensus is emerging both in industry and academia, that molecules able to intervene in the aging process may contain the potential to transform both societies and healthcare.
Source: Aging
Authors: Daniela Bakula, Alexander M. Aliper, Polina Mamoshina, Michael A. Petr, Amanuel Teklu, Joseph A. Baur, Judith Campisi, Collin Y. Ewald, Anastasia Georgievskaya, Vadim N. Gladyshev, Olga Kovalchuk, Dudley W. Lamming, Martijn S. Luijsterburg, Alejandro Martín-Montalvo, Stuart Maudsley, Garik V. Mkrtchyan, Alexey Moskalev, S. Jay Olshansky, Ivan V. Ozerov, Alexander Pickett, Michael Ristow, Alex Zhavoronkov, Morten Scheibye-Knudsen
Institutions: University of Copenhagen, Insilico Medicine (United States), University of Pennsylvania, Buck Institute for Research on Aging, Lawrence Berkeley National Laboratory, ETH Zurich, Institute of Translational Medicine, Brigham and Women's Hospital, Harvard University, Lomonosov Moscow State University, University of Lethbridge, Alberta University of the Arts, University of Wisconsin–Madison, Leiden University Medical Center, Consejo Superior de Investigaciones Científicas, Centro Andaluz de Biología Molecular y Medicina Regenerativa, Universidad de Sevilla, Universidad Pablo de Olavide, University of Antwerp, VIB-UAntwerp Center for Molecular Neurology, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow Institute of Physics and Technology, Institute of Biology of Komi Scientific Centre, University of Illinois Chicago
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: green
Funders: National Science Foundation, U.S. Department of Veterans Affairs, Glenn Foundation for Medical Research, University of Wisconsin-Madison, Strong, European Commission, Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Fondation pour la Recherche Médicale, Fonds Wetenschappelijk Onderzoek, Nederlandse Organisatie voor Wetenschappelijk Onderzoek, Novo Nordisk, Leids Universitair Medisch Centrum, Novo Nordisk Fonden, National Institutes of Health, Instituto de Salud Carlos III, National Institute on Aging
Awards: G1386593725, Regulatory Mechanisms in Transcription-Coupled DNA repair, Evaluación de la inhibición de la liponeogénesis como arma terapéutica para la protección contra el síndrome metabólico y la promoción de un envejecimiento saludable, Molecular Mechanisms of Rapamycin's effects on Health and longevity., Intervention in Progeria by Alterations in dietary macronutrient Composition, G3559523986, G4633165539, The regulation of health and longevity by branched-chain amino acids, G6170680229, The role of extracellular matrix enhancement in promoting healthy aging
OpenAlex ID: W2900536852
